Vaccine Company, Inc.
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| mRNA Vaccine Targeting Epstein-Barr Virus (EBV) in Healthy Young Adults (NCT07557602) | Vaccine Company, Inc. | 2026-05-04 |
| Study of VXCO-100, a SARS-CoV Candidate Vaccine, in Adults in the Republic of South Africa (NCT05938075) | Vaccine Company, Inc. | 2023-08-04 |
| Study of VXCO-100, a SARS-CoV Candidate Vaccine in Healthy Adults in the United States (NCT05870839) | Vaccine Company, Inc. | 2023-05-11 |
Track Vaccine Company, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.